5 papers analyzed
These studies suggest that ethosomal gels, loaded with various active compounds like andrographolide, naproxen sodium, and quercetin, show potential in reducing inflammation and improving symptoms in rheumatoid arthritis treatment.
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that primarily affects joints, leading to pain, swelling, and potential loss of function. Traditional treatments often have limited efficacy and significant side effects. Recent research has focused on the development of ethosome-based gels for the transdermal delivery of therapeutic agents to improve bioavailability and efficacy in treating RA.
Enhanced Bioavailability and Efficacy of Ethosome-Based Gels:
Improved Skin Penetration and Drug Delivery:
Anti-inflammatory and Anti-rheumatic Activity:
Mechanisms of Action:
Ethosome-based gels represent a promising approach for the treatment of rheumatoid arthritis. These formulations enhance the bioavailability and skin penetration of therapeutic agents, leading to improved anti-inflammatory and anti-rheumatic effects. By effectively delivering active compounds to deeper skin layers and inhibiting pro-inflammatory pathways, ethosome-based gels offer a potential alternative to conventional RA therapies with better clinical outcomes.
What is the Sustainable urban planning and development?
What is the Microfinance's impact on poverty alleviation?
What is the influence of urban design on public health outcomes?
What is People Analytics
Is DHEA safe?
visual cognition